JoVE Logo

로그인

7.20 : Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue drug concentration can be mathematically expressed, with Cart and Cven representing the arterial and venous blood drug concentrations, respectively.

Physiological models can be categorized into blood-flow-limited models and diffusion-limited models. In a blood-flow-limited model, drug distribution is primarily regulated by blood flow to the tissue. In contrast, in a diffusion-limited model, the diffusion rate across tissue barriers predominantly controls drug distribution.

The advantages of these models lie in their ability to enhance understanding of complex drug interactions within the body, providing valuable insights for pharmacokinetic studies. Equations such as those expressing the rate of change in tissue drug concentration play a crucial role in quantitatively understanding the dynamics of drug distribution within physiological models. Overall, physiological models in pharmacokinetics serve as powerful tools for understanding the intricate processes involved in drug distribution and elimination within the human body, offering valuable insights for pharmaceutical research and development.

Tags

PharmacokineticsPhysiological ModelsDrug DistributionDrug EliminationDrug UptakePartition CoefficientBlood Flow RateTissue Drug ConcentrationBlood flow limited ModelsDiffusion limited ModelsDrug InteractionsPharmacokinetic StudiesPharmaceutical Research

장에서 7:

article

Now Playing

7.20 : Model Approaches for Pharmacokinetic Data: Physiological Models

Pharmacokinetic Models

26 Views

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

69 Views

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

61 Views

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

131 Views

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

143 Views

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

49 Views

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

130 Views

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

45 Views

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

177 Views

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

269 Views

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

104 Views

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

70 Views

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

82 Views

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

295 Views

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

181 Views

See More

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유